101 related articles for article (PubMed ID: 29608403)
1. Design, synthesis, molecular docking and anti-hepatocellular carcinoma evaluation of novel acyclic pyridine thioglycosides.
Elgemeie GH; Fathy NM; Farag AB; Alkhursani SA
Nucleosides Nucleotides Nucleic Acids; 2018 Mar; 37(3):186-198. PubMed ID: 29608403
[TBL] [Abstract][Full Text] [Related]
2. Antimetabolites: Design, synthesis, and cytotoxic evaluation of novel dihydropyridine thioglycosides and pyridine thioglycosides.
Elgemeie GH; Fathy NM; Farag AB; Alkursani SA
Nucleosides Nucleotides Nucleic Acids; 2017 May; 36(5):355-377. PubMed ID: 28387606
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and in vitro anti-hepatocellular carcinoma of novel thymine thioglycoside analogs as new antimetabolic agents.
Elgemeie GH; Farag AB
Nucleosides Nucleotides Nucleic Acids; 2017 May; 36(5):328-342. PubMed ID: 28362220
[TBL] [Abstract][Full Text] [Related]
4. Novel dihydropyridine thioglycosides and their corresponding dehydrogenated forms as potent anti-hepatocellular carcinoma agents.
Elgemeie GH; El-Naggar DH
Nucleosides Nucleotides Nucleic Acids; 2018; 37(4):199-216. PubMed ID: 29723119
[TBL] [Abstract][Full Text] [Related]
5. Novel Nucleoside Analogues: First Synthesis of Pyridine-4-Thioglycosides and Their Cytotoxic Evaluation.
Elgemeie G; Abou-Zeid M; Alsaid S; Hebishy A; Essa H
Nucleosides Nucleotides Nucleic Acids; 2015; 34(10):659-73. PubMed ID: 26462063
[TBL] [Abstract][Full Text] [Related]
6. Human dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells.
Antosiewicz A; Jarmuła A; Przybylska D; Mosieniak G; Szczepanowska J; Kowalkowska A; Rode W; Cieśla J
J Biomol Struct Dyn; 2017 May; 35(7):1474-1490. PubMed ID: 27187663
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Anticancer Activity of New 1-Thia-4-azaspiro[4.5]decane, Their Derived Thiazolopyrimidine and 1,3,4-Thiadiazole Thioglycosides.
Flefel EM; El-Sayed WA; Mohamed AM; El-Sofany WI; Awad HM
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117699
[TBL] [Abstract][Full Text] [Related]
8. Substrate channeling between the human dihydrofolate reductase and thymidylate synthase.
Wang N; McCammon JA
Protein Sci; 2016 Jan; 25(1):79-86. PubMed ID: 26096018
[TBL] [Abstract][Full Text] [Related]
9. Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking.
Eldehna WM; Fares M; Ibrahim HS; Aly MH; Zada S; Ali MM; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA
Eur J Med Chem; 2015 Jul; 100():89-97. PubMed ID: 26071861
[TBL] [Abstract][Full Text] [Related]
10. Kinetic reaction scheme for the dihydrofolate reductase domain of the bifunctional thymidylate synthase-dihydrofolate reductase from Leishmania major.
Liang PH; Anderson KS
Biochemistry; 1998 Sep; 37(35):12206-12. PubMed ID: 9724534
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives.
Fargualy AM; Habib NS; Ismail KA; Hassan AM; Sarg MT
Eur J Med Chem; 2013 Aug; 66():276-95. PubMed ID: 23811090
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2-d] pyrimidine analogues as antifolate antitumor agents.
Tian C; Wang M; Han Z; Fang F; Zhang Z; Wang X; Liu J
Eur J Med Chem; 2017 Sep; 138():630-643. PubMed ID: 28711701
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening reveals allosteric inhibitors of the Toxoplasma gondii thymidylate synthase-dihydrofolate reductase.
Sharma H; Landau MJ; Sullivan TJ; Kumar VP; Dahlgren MK; Jorgensen WL; Anderson KS
Bioorg Med Chem Lett; 2014 Feb; 24(4):1232-5. PubMed ID: 24440298
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antimalarial activity, heme binding and docking studies of N-substituted 4-aminoquinoline-pyrimidine molecular hybrids.
Maurya SS; Khan SI; Bahuguna A; Kumar D; Rawat DS
Eur J Med Chem; 2017 Mar; 129():175-185. PubMed ID: 28222317
[TBL] [Abstract][Full Text] [Related]
15.
Keshari AK; Singh AK; Raj V; Rai A; Trivedi P; Ghosh B; Kumar U; Rawat A; Kumar D; Saha S
Drug Des Devel Ther; 2017; 11():1623-1642. PubMed ID: 28615927
[TBL] [Abstract][Full Text] [Related]
16. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
Ng HL; Chen S; Chew EH; Chui WK
Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer activity of new [(Indolyl)pyrazolyl]-1,3,4-oxadiazole thioglycosides and acyclic nucleoside analogs.
El-Sayed WA; El-Sofany WI; Hussein HAR; Fathy NM
Nucleosides Nucleotides Nucleic Acids; 2017 Jul; 36(7):474-495. PubMed ID: 28613111
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in Vitro Anti-Tumor Activity of A New Class of Acyclic Thioglycosides.
Elgemeie GH; Saber NM
Nucleosides Nucleotides Nucleic Acids; 2015; 34(7):463-74. PubMed ID: 26158566
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents.
El-Naggar AM; Abou-El-Regal MM; El-Metwally SA; Sherbiny FF; Eissa IH
Mol Divers; 2017 Nov; 21(4):967-983. PubMed ID: 28815411
[TBL] [Abstract][Full Text] [Related]
20. Probing the role of parasite-specific, distant structural regions on communication and catalysis in the bifunctional thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum.
Dasgupta T; Anderson KS
Biochemistry; 2008 Feb; 47(5):1336-45. PubMed ID: 18189414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
